MedTrace Logo

aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial

NCT06288659 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2026-07-07

No results posted yet for this study

Summary

ASTIM is a multicenter, prospective, randomised, blinded end-point assessed trial, to investigate the efficacy and safety of treatment based on intracranial pressure monitoring in improving the prognosis of patients with aneurysmal subarachnoid hemorrhage.

Conditions

  • Aneurysmal Subarachnoid Hemorrhage
  • Intacranial Hypertension

Interventions

DEVICE

Intraventricular intracranial pressure monitoring

The postoperative management of ICP is guided by quantifiable Intraventricular ICP parameters. The remaining treatments are consistent with those in the control group.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Wei Zhu, Ph.D. · Department of Neurosurgery, Huashan Hospital, Fudan University

  • Xuehai Wu, Ph.D. · Department of Neurosurgery, Huashan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-19
Primary Completion
2026-07-29
Completion
2026-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06288659 on ClinicalTrials.gov